Health In Tech officer plans 18,334-share sale

Health In Tech’s Chief Growth Officer has filed to sell 18,334 HIT shares under Rule 144 pursuant to a Rule 10b5-1 plan.

Rhea-AI Filing Summary

Health In Tech, Inc. (HIT) insider Hasan Zain Syed, identified as Chief Growth Officer, has filed a notice of intent to sell up to 18,334 shares of common stock under Rule 144. The planned sales, with an aggregate market value of $17,169.79, may begin on or about September 11, 2026, through APEX CLEARING on the Nasdaq Stock Market and will be executed pursuant to a Rule 10b5-1 trading plan.

Key Figures

Shares to be sold: 18,334 shares Aggregate market value: $17,169.79 Shares outstanding: 53,834,658 shares +2 more

5 metrics

Shares to be sold 18,334 shares Proposed sale of Health In Tech, Inc. common stock under Rule 144

Aggregate market value $17,169.79 Aggregate market value of the 18,334 shares proposed to be sold

Shares outstanding 53,834,658 shares Number of shares of the class outstanding referenced in the notice

Approximate sale date September 11, 2026 Planned start date for sales of the shares under Rule 144

Date acquired December 26, 2025 Date associated with Restricted Stock Award vesting for the shares

Key Terms

Rule 144, Restricted Stock Award Vesting, Rule 10b5-1 plan

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Award Vesting financial

"Common | 12/26/2025 | Restricted Stock Award Vesting | Health In Tech, Inc."

Rule 10b5-1 plan regulatory

"Remarks | Shares will be sold pursuant to 10b5-1 plan"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider sale is disclosed for HIT in this Form 144?

The Chief Growth Officer, Hasan Zain Syed, filed to sell up to 18,334 shares of Health In Tech, Inc. common stock under Rule 144, with an aggregate market value of $17,169.79, according to the notice of proposed sale.

When may the HIT shares covered by this Form 144 be sold?

The notice states the approximate date of sale as September 11, 2026. Sales of the 18,334 shares of Health In Tech, Inc. common stock are expected to occur on or after that date, subject to Rule 144 conditions.

Under what plan will the HIT insider’s shares be sold?

The remarks explain that the shares will be sold pursuant to a Rule 10b5-1 plan. Such a plan allows pre-arranged trading of securities, and the notice ties the planned sale of 18,334 shares of Health In Tech, Inc. to this arrangement.

How many Health In Tech (HIT) shares are outstanding as referenced in the Form 144?

The securities information section references 53,834,658 shares of Health In Tech, Inc. common stock as the number of shares of the class outstanding, providing context for the planned sale of 18,334 shares under Rule 144.

What is the origin of the HIT shares proposed for sale in this Form 144?

The Form 144 describes the securities to be sold as common stock acquired on December 26, 2025 through a Restricted Stock Award vesting from Health In Tech, Inc., with the amount tied to the 18,334 shares proposed for sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 11:24 AM EDT Accepted by SEC EDGAR 09/10/2026 - 11:24 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002102674
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Health In Tech, Inc.
SEC File Number	001-42449
Address of Issuer	701 S. Colorado Ave, Suite 1. Stuart FLORIDA 34994
Phone	8883730333
Name of Person for Whose Account the Securities are To Be Sold	Hasan Zain Syed
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Chief Growth Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	APEX CLEARING 350 N ST. PAUL ST, SUITE 300 DALLAS TX 75201	18334	17169.79	53834658	09/11/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/26/2025	Restricted Stock Award Vesting	Health In Tech, Inc.			18334	12/25/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Shares will be sold pursuant to 10b5-1 plan
Date of Notice	09/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Zain Syed Hasan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)